| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_066828a4b6f7a816447cb8ba1bcbb40e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1214 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 |
| filingDate |
1987-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eeca2e28aeb3f8f02a126b07be4cec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad447f6e0619cd7b17b751a901fde18e |
| publicationDate |
1988-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0252064-A2 |
| titleOfInvention |
Preparations active against pseudomonas aeruginosa infections, and process for their preparation |
| abstract |
Preparations effective against Pseudomonas aeruginosa infections, e.g. Vaccines for active immunization and antibody-containing preparations for passive protection and methods for their preparation are described.n n n The vaccines contain protective flagella (H) antigens of the H serotype a and b, which consist of monomeric components, each monomeric component is composed of specific amino acids with a specific N-terminal amino acid sequence and has a specific molecular weight. The vaccines are made from purified Flagella (H) antigen solutions. The preparations containing immunoglobulin G contain flagella (H) antibodies obtained from the blood plasma of human donors or mammals immunized with protective flagella (H) antigens. They can be purified by affinity chromatography procedures. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7029684-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0357585-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7989162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701982-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9702005-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8367317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0357585-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9832769-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7371394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211633-B2 |
| priorityDate |
1986-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |